A2A Pharmaceuticals to Create SARS-CoV-2 Main Protease Inhibitors for COVID-19 Treatment with Help of Laxai Life Sciences Pvt. Ltd.
Bengaluru, NFAPost: A2A Pharmaceuticals has signed an agreement with Laxai Life Sciences…
Search
Have an existing account?
Sign In
Tag: covid-19 treatment
